← Open Payments lookup

JONATHAN MELIUS: Open Payments

NPI 1194034157 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,560 in 121 payments from 14 companies in 2025. Trend: 2023 $1,413 · 2024 $1,416 · 2025 $2,560

Food & beverage: $2,449Education: $111
CompanyPaymentsAmount
ABBVIE INC.25$526
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$361
Janssen Pharmaceuticals, Inc16$350
Teva Pharmaceuticals USA, Inc.13$323
Otsuka America Pharmaceutical, Inc.7$174
Neurocrine BioSciences, Inc.9$163
Takeda Pharmaceuticals U.S.A., Inc.7$129
Axsome Therapeutics, Inc.6$126
Lundbeck LLC5$119
Supernus Pharmaceuticals, Inc.4$79

Products named: VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, INGREZZA, TRINTELLIX, Auvelity, INVEGA SUSTENNA.

Industry payments across NJ — which companies pay providers there.